Oncology

Cancer, called malignancy as well, is a class of diseases described by out-of-control cell proliferation. According to the announcements of World Health Organization (WHO), cancer is the second leading reason of death worldwide (around 13% of all deaths in 2008). The disease arises from a transformation that occurs in one normal single cell in a multistage process towards tumorigenesis. Management is not accomplished with a single therapeutic; patients often get a combination of therapies dependent

Medical Marijuana "Oh! You smoke weed?",well you must be a Drug Addict." I think people who smoke weed for pain management typically do it as an excues to get high". These are just some of the things you may hear people say about marijuana. But did you know marijuana has been used for years to treat many different types of illness such as AIDS, cancer, glaucoma, even back pain. If you had a child going through chemo, or a grandarent with alzheimers, or a child with sezures, wouldnt you want them

My mom was diagnosed with pancreatic cancer stage IV last July. “I could believe what was happening to me, at the age of 44 I considered myself a healthy person, I was never sick, I never smoked, I was highly active and had a healthy diet. I couldn't find a possible explanation that justified this illness.” she said. It was really though for my family, we couldn't even say the word “cancer” for a few months. We became angry because we thought that my mom didn’t deserved that. The doctors were confident

The Centers for Disease Control and Prevention (CDC) (2013) defines cancer clusters as a larger than anticipated amount of similar cancer cases arising at a given time among members of a defined community. Cancer clusters present many challenges due to the complexity of the analytic process and the abundance of inquiries and concerns. Because the research and studies of cancer clusters in the United States have uncovered few conclusive determinants, many states are hesitant in dedicating excess resources

The incidence of thyroid cancer is rapidly rising in the US accounting for 62,980 cases with 1890 deaths every year[1]. It is the seventh most common cancer diagnosed in women and peaks earlier than in men. Despite its high prevalence, death rate from thyroid cancer is fairly stable from past many years. In general, thyroid cancer offers a good prognosis with an overall survival rate of approximately 90%[2]. Papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC) termed as differentiated

Health care providers are often confronted by various ethical dilemmas in their course of practice. When a person’s values and beliefs conflicts with another person’s values and beliefs, an ethical dilemma occurs. An example of an ethical dilemma in a healthcare setting is when a nurse interacts with an elderly woman who is diagnosed with terminal breast cancer and hears that she is in a lot of pain and wishes to end her sufferings. When confronting this issue, it is beneficial to follow Jonsen’s

Physical Settings To date MSK has twenty-four facilities throughout New York and New Jersey providing a multitude of inpatient and outpatient services associated with the study, diagnosis and treatment of various forms of cancer. The Memorial hospital accommodates 471 beds, a 72,000-square-foot surgical center and state-of-the-art outpatient treatment center (Memorial Sloan Kettering Cancer Center, 2015c). MSK houses more than 35 core facilities with research being conducted in over 120 laboratories

Title: Targeted Therapy in Ovarian Cancer Authors: Hui Jun, Lim1 and William, Ledger2 Affiliations: University of New South Wales, Australia1, School of Women and Children’s Health, Prince of Wales Hospital, Sydney, Australia2   Abstract Among female-specific cancers worldwide, ovarian cancer is the leading cause of death from gynaecologic malignancy in the Western world. Despite radical surgery and initial high response rates to first-line chemotherapy, up to 70% of patients experience relapses

Reflection Assignment Working as an intern caring for patients with cancer on the Adjunctive Cancer Care (ACC) shift at the Robert Schad Naturopathic Clinic (RSNC) for this past year has been a great learning experience. Although it had its own unique set of challenges, it has been a real privilege to be a trusted part of the patients care experience. With the privilege of being a part of patient’s health care teams, there were many challenging aspects working with terminally ill patients. I

Cancer is the one of the leading cause of death both in economically developed as well as developing countries (Jemal, Bray et al. 2011). Although a number of chemotherapeutic drugs can considerably shrink tumor sizes, but they often fail to eradicate tumors completely (Sun, Wen et al. 2011) or have other limitations like toxicity and very high cost. Resistance to chemotherapeutic regime is a major reason nowadays for failure of anticancer treatments. Thus, there is always the quest for a molecule